1. Home
  2. CENN vs CURX Comparison

CENN vs CURX Comparison

Compare CENN & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cenntro Electric Group Limited

CENN

Cenntro Electric Group Limited

HOLD

Current Price

$3.27

Market Cap

9.9M

ML Signal

HOLD

CURX

Curanex Pharmaceuticals Inc

HOLD

Current Price

$0.23

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENN
CURX
Founded
2013
2018
Country
United States
United States
Employees
N/A
6
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
9.4M
IPO Year
2017
2025

Fundamental Metrics

Financial Performance
Metric
CENN
CURX
Price
$3.27
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.5K
61.8K
Earning Date
04-15-2026
09-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,080,161.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.21
52 Week High
$4.73
$9.18

Technical Indicators

Market Signals
Indicator
CENN
CURX
Relative Strength Index (RSI) 37.83 30.90
Support Level $0.14 N/A
Resistance Level $4.50 $0.40
Average True Range (ATR) 0.15 0.03
MACD -0.03 -0.00
Stochastic Oscillator 20.97 7.43

Price Performance

Historical Comparison
CENN
CURX

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, iChassis, Avantier, Teemak, Bison Motor, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the Europe, and also has a presence in America, Asia, and other regions.

About CURX Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.

Share on Social Networks: